Position in CLDX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$15,058,998
+$8,165,133 QoQ
Shares Held
404,703
+86.2% QoQ
Ownership
0.515%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 252 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Sep 30, 2024CallValue
$1,040,094
CallShares
30,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. CLDX ranks #28 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in CLDX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,058,998 | 404,703 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $6,893,865 | 217,335 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $405,281 | 14,922 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $579,331 | 22,394 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $2,018,718 | 99,200 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,371,986 | 130,688 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,016,200 | 119,359 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,724,312 | 50,730 | Shares | Defined | 2024-11-12 | |
| 2024-09-30 | $1,040,094 | 30,600 | Call | Defined | 2024-11-12 | |
| 2024-06-30 | $935,057 | 25,265 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $7,595,730 | 180,980 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,472,443 | 62,341 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,908,648 | 69,355 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $2,403,396 | 70,834 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $4,242,221 | 117,905 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,830,061 | 63,497 | Shares | Defined | 2023-02-09 | |
| 2022-12-31 | $445,700 | 10,000 | Call | Defined | 2023-02-09 | |
| 2022-09-30 | $281,100 | 10,000 | Call | Defined | 2022-11-10 | |
| 2022-09-30 | $5,324,369 | 189,412 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,235,200 | 120,000 | Call | Defined | 2022-08-10 | |
| 2022-06-30 | $4,197,051 | 155,677 | Shares | Defined | 2022-08-10 | |
| 2022-06-30 | $269,600 | 10,000 | Put | Defined | 2022-08-10 | |
| 2022-03-31 | $6,130,800 | 180,000 | Call | Defined | 2022-05-12 | |
| 2022-03-31 | $2,163,456 | 63,519 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $4,600,014 | 119,048 | Shares | Defined | 2022-02-10 | |
| 2021-12-31 | $6,955,200 | 180,000 | Call | Defined | 2022-02-10 | |
| 2021-09-30 | $5,901,592 | 109,309 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,021,293 | 120,254 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,569,526 | 173,278 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $623,554 | 35,591 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||